125 related articles for article (PubMed ID: 9865512)
1. Cardiovascular effects of noradrenaline in hypovolemic haemorrhage: role of inducible nitric oxide synthase.
Tabrizchi R
Eur J Pharmacol; 1998 Nov; 361(2-3):227-34. PubMed ID: 9865512
[TBL] [Abstract][Full Text] [Related]
2. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.
Stenger S; Thuring H; Rollinghoff M; Manning P; Bogdan C
Eur J Pharmacol; 1995 Dec; 294(2-3):703-12. PubMed ID: 8750736
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
4. The influence of tumour necrosis factor-alpha on the cardiovascular system of anaesthetized rats.
Tabrizchi R
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):307-21. PubMed ID: 11284446
[TBL] [Abstract][Full Text] [Related]
5. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
Bower EA; Law AC
Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
[TBL] [Abstract][Full Text] [Related]
6. Effect of selective inhibitors of nitric oxide synthesis on the course of experimental hemorrhagic shock.
Remizova MI; Gerbut KA; Kochetygov NI
Bull Exp Biol Med; 2010 Oct; 149(5):571-4. PubMed ID: 21165389
[TBL] [Abstract][Full Text] [Related]
7. The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock.
Menezes JM; Hierholzer C; Watkins SC; Billiar TR; Peitzman AB; Harbrecht BG
Shock; 2002 Jan; 17(1):13-8. PubMed ID: 11795663
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
Szabó C; Mitchell JA; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):786-92. PubMed ID: 7682137
[TBL] [Abstract][Full Text] [Related]
9. L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats.
Fishman D; Liaudet L; Lazor R; Perret CH; Feihl F
Crit Care Med; 1997 Mar; 25(3):469-75. PubMed ID: 9118664
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia.
Datta P; Magder S
Am J Respir Crit Care Med; 1999 Dec; 160(6):1987-93. PubMed ID: 10588618
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric oxide synthase in persistent pain.
Budziñski M; Misterek K; Gumulka W; Dorociak A
Life Sci; 2000; 66(4):301-5. PubMed ID: 10665981
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
14. Unaltered vasoconstrictor responsiveness after iNOS inhibition in lungs from chronically hypoxic rats.
Resta TC; O'Donaughy TL; Earley S; Chicoine LG; Walker BR
Am J Physiol; 1999 Jan; 276(1):L122-30. PubMed ID: 9887064
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection.
Vos IH; Joles JA; Schurink M; Weckbecker G; Stojanovic T; Rabelink TJ; Gröne HJ
Eur J Pharmacol; 2000 Mar; 391(1-2):31-8. PubMed ID: 10720632
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
17. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
[TBL] [Abstract][Full Text] [Related]
18. Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally-induced septic shock in rats.
Kadoi Y; Goto F
Anesth Analg; 2004 Jul; 99(1):212-220. PubMed ID: 15281532
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.
Sakamoto K; Yonoki Y; Kubota Y; Kuwagata M; Saito M; Nakahara T; Ishii K
Exp Eye Res; 2006 Mar; 82(3):512-8. PubMed ID: 16198335
[TBL] [Abstract][Full Text] [Related]
20. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW
Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
